The N-terminus of CiP can specifically bind to the membrane of lung cancer cells, and the target paired with CiP is the erythropoietin hepatocellular carcinoma receptor A2 (EPHA2) on the surface of lung cancer cells. This evidence concerns the gene EPHA2 and lung carcinoma.